The global HIV Diagnostics market is projected to grow from US$ 2878.6 million in 2023 to US$ 4697.7 million by 2029, at a Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period.

HIV Diagnostics Market

The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.

Market Analysis and Insights: Global HIV Diagnostics Market

Owing to the technological development of disease diagnostic tests and the anticipated development and commercialization of novel, regulatory authorities approved POC and rapid CD4, p24 antigen and EID tests, it is expected that all the major regional market segments will witness an increase in market demand over the forecast period.

Report Includes

This report presents an overview of global market for HIV Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of HIV Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for HIV Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the HIV Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global HIV Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for HIV Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott, Abbott Healthcare, Abbvie Inc., Brsitol-Myers Squibb, Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, VIIV Healthcare and BD Biosciences, etc.

Scope of HIV Diagnostics Market Report

Report Metric	Details
Report Name	HIV Diagnostics Market
Accounted market size in 2023	US$ 2878.6 million
Forecasted market size in 2029	US$ 4697.7 million
CAGR	8.5
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Consumables Assay, Kits and Reagents Other Consumables Instruments Software and Services
Segment by Application	Antibody Tests Viral Load Tests CD4 Tests Tests for Early Infant Diagnosis Tests for Viral Identification
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Abbott Healthcare, Abbvie Inc., Brsitol-Myers Squibb, Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, VIIV Healthcare, BD Biosciences, Beckman Coulter, Partec, Sysmex, Apogee Flow Systems, PointCare Technologies Inc., Zyomyx Inc., Mylan inc., Roche Diagnostics, Siemens Healthcare, Qiagen, BioMerieux
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of HIV Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HIV Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is HIV Diagnostics Market growing?

Ans: The HIV Diagnostics Market witnessing a CAGR of 8.5 during the forecast period 2023-2029.

What is the HIV Diagnostics Market size in 2029?

Ans: The global HIV Diagnostics market is projected to grow from US$ 2878.6 million in 2023 to US$ 4697.7 million by 2029, at a Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global HIV Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Consumables

1.2.3 Assay, Kits and Reagents

1.2.4 Other Consumables

1.2.5 Instruments

1.2.6 Software and Services

1.3 Market by Application

1.3.1 Global HIV Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Antibody Tests

1.3.3 Viral Load Tests

1.3.4 CD4 Tests

1.3.5 Tests for Early Infant Diagnosis

1.3.6 Tests for Viral Identification

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global HIV Diagnostics Market Perspective (2018-2029)

2.2 Global HIV Diagnostics Growth Trends by Region

2.2.1 HIV Diagnostics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 HIV Diagnostics Historic Market Size by Region (2018-2023)

2.2.3 HIV Diagnostics Forecasted Market Size by Region (2024-2029)

2.3 HIV Diagnostics Market Dynamics

2.3.1 HIV Diagnostics Industry Trends

2.3.2 HIV Diagnostics Market Drivers

2.3.3 HIV Diagnostics Market Challenges

2.3.4 HIV Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue HIV Diagnostics by Players

3.1.1 Global HIV Diagnostics Revenue by Players (2018-2023)

3.1.2 Global HIV Diagnostics Revenue Market Share by Players (2018-2023)

3.2 Global HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of HIV Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global HIV Diagnostics Market Concentration Ratio

3.4.1 Global HIV Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by HIV Diagnostics Revenue in 2022

3.5 Global Key Players of HIV Diagnostics Head office and Area Served

3.6 Global Key Players of HIV Diagnostics, Product and Application

3.7 Global Key Players of HIV Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 HIV Diagnostics Breakdown Data by Type

4.1 Global HIV Diagnostics Historic Market Size by Type (2018-2023)

4.2 Global HIV Diagnostics Forecasted Market Size by Type (2024-2029)

5 HIV Diagnostics Breakdown Data by Application

5.1 Global HIV Diagnostics Historic Market Size by Application (2018-2023)

5.2 Global HIV Diagnostics Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America HIV Diagnostics Market Size (2018-2029)

6.2 North America HIV Diagnostics Market Size by Type

6.2.1 North America HIV Diagnostics Market Size by Type (2018-2023)

6.2.2 North America HIV Diagnostics Market Size by Type (2024-2029)

6.2.3 North America HIV Diagnostics Market Share by Type (2018-2029)

6.3 North America HIV Diagnostics Market Size by Application

6.3.1 North America HIV Diagnostics Market Size by Application (2018-2023)

6.3.2 North America HIV Diagnostics Market Size by Application (2024-2029)

6.3.3 North America HIV Diagnostics Market Share by Application (2018-2029)

6.4 North America HIV Diagnostics Market Size by Country

6.4.1 North America HIV Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America HIV Diagnostics Market Size by Country (2018-2023)

6.4.3 North America HIV Diagnostics Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe HIV Diagnostics Market Size (2018-2029)

7.2 Europe HIV Diagnostics Market Size by Type

7.2.1 Europe HIV Diagnostics Market Size by Type (2018-2023)

7.2.2 Europe HIV Diagnostics Market Size by Type (2024-2029)

7.2.3 Europe HIV Diagnostics Market Share by Type (2018-2029)

7.3 Europe HIV Diagnostics Market Size by Application

7.3.1 Europe HIV Diagnostics Market Size by Application (2018-2023)

7.3.2 Europe HIV Diagnostics Market Size by Application (2024-2029)

7.3.3 Europe HIV Diagnostics Market Share by Application (2018-2029)

7.4 Europe HIV Diagnostics Market Size by Country

7.4.1 Europe HIV Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe HIV Diagnostics Market Size by Country (2018-2023)

7.4.3 Europe HIV Diagnostics Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China HIV Diagnostics Market Size (2018-2029)

8.2 China HIV Diagnostics Market Size by Type

8.2.1 China HIV Diagnostics Market Size by Type (2018-2023)

8.2.2 China HIV Diagnostics Market Size by Type (2024-2029)

8.2.3 China HIV Diagnostics Market Share by Type (2018-2029)

8.3 China HIV Diagnostics Market Size by Application

8.3.1 China HIV Diagnostics Market Size by Application (2018-2023)

8.3.2 China HIV Diagnostics Market Size by Application (2024-2029)

8.3.3 China HIV Diagnostics Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia HIV Diagnostics Market Size (2018-2029)

9.2 Asia HIV Diagnostics Market Size by Type

9.2.1 Asia HIV Diagnostics Market Size by Type (2018-2023)

9.2.2 Asia HIV Diagnostics Market Size by Type (2024-2029)

9.2.3 Asia HIV Diagnostics Market Share by Type (2018-2029)

9.3 Asia HIV Diagnostics Market Size by Application

9.3.1 Asia HIV Diagnostics Market Size by Application (2018-2023)

9.3.2 Asia HIV Diagnostics Market Size by Application (2024-2029)

9.3.3 Asia HIV Diagnostics Market Share by Application (2018-2029)

9.4 Asia HIV Diagnostics Market Size by Region

9.4.1 Asia HIV Diagnostics Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia HIV Diagnostics Market Size by Region (2018-2023)

9.4.3 Asia HIV Diagnostics Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America HIV Diagnostics Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America HIV Diagnostics Market Size by Type

10.2.1 Middle East, Africa, and Latin America HIV Diagnostics Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America HIV Diagnostics Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America HIV Diagnostics Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America HIV Diagnostics Market Size by Application

10.3.1 Middle East, Africa, and Latin America HIV Diagnostics Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America HIV Diagnostics Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America HIV Diagnostics Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America HIV Diagnostics Market Size by Country

10.4.1 Middle East, Africa, and Latin America HIV Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America HIV Diagnostics Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America HIV Diagnostics Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott HIV Diagnostics Introduction

11.1.4 Abbott Revenue in HIV Diagnostics Business (2018-2023)

11.1.5 Abbott Recent Developments

11.2 Abbott Healthcare

11.2.1 Abbott Healthcare Company Details

11.2.2 Abbott Healthcare Business Overview

11.2.3 Abbott Healthcare HIV Diagnostics Introduction

11.2.4 Abbott Healthcare Revenue in HIV Diagnostics Business (2018-2023)

11.2.5 Abbott Healthcare Recent Developments

11.3 Abbvie Inc.

11.3.1 Abbvie Inc. Company Details

11.3.2 Abbvie Inc. Business Overview

11.3.3 Abbvie Inc. HIV Diagnostics Introduction

11.3.4 Abbvie Inc. Revenue in HIV Diagnostics Business (2018-2023)

11.3.5 Abbvie Inc. Recent Developments

11.4 Brsitol-Myers Squibb

11.4.1 Brsitol-Myers Squibb Company Details

11.4.2 Brsitol-Myers Squibb Business Overview

11.4.3 Brsitol-Myers Squibb HIV Diagnostics Introduction

11.4.4 Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2018-2023)

11.4.5 Brsitol-Myers Squibb Recent Developments

11.5 Janssen Therapeutics

11.5.1 Janssen Therapeutics Company Details

11.5.2 Janssen Therapeutics Business Overview

11.5.3 Janssen Therapeutics HIV Diagnostics Introduction

11.5.4 Janssen Therapeutics Revenue in HIV Diagnostics Business (2018-2023)

11.5.5 Janssen Therapeutics Recent Developments

11.6 Gilead Sciences

11.6.1 Gilead Sciences Company Details

11.6.2 Gilead Sciences Business Overview

11.6.3 Gilead Sciences HIV Diagnostics Introduction

11.6.4 Gilead Sciences Revenue in HIV Diagnostics Business (2018-2023)

11.6.5 Gilead Sciences Recent Developments

11.7 Merck & Co. Inc

11.7.1 Merck & Co. Inc Company Details

11.7.2 Merck & Co. Inc Business Overview

11.7.3 Merck & Co. Inc HIV Diagnostics Introduction

11.7.4 Merck & Co. Inc Revenue in HIV Diagnostics Business (2018-2023)

11.7.5 Merck & Co. Inc Recent Developments

11.8 VIIV Healthcare

11.8.1 VIIV Healthcare Company Details

11.8.2 VIIV Healthcare Business Overview

11.8.3 VIIV Healthcare HIV Diagnostics Introduction

11.8.4 VIIV Healthcare Revenue in HIV Diagnostics Business (2018-2023)

11.8.5 VIIV Healthcare Recent Developments

11.9 BD Biosciences

11.9.1 BD Biosciences Company Details

11.9.2 BD Biosciences Business Overview

11.9.3 BD Biosciences HIV Diagnostics Introduction

11.9.4 BD Biosciences Revenue in HIV Diagnostics Business (2018-2023)

11.9.5 BD Biosciences Recent Developments

11.10 Beckman Coulter

11.10.1 Beckman Coulter Company Details

11.10.2 Beckman Coulter Business Overview

11.10.3 Beckman Coulter HIV Diagnostics Introduction

11.10.4 Beckman Coulter Revenue in HIV Diagnostics Business (2018-2023)

11.10.5 Beckman Coulter Recent Developments

11.11 Partec

11.11.1 Partec Company Details

11.11.2 Partec Business Overview

11.11.3 Partec HIV Diagnostics Introduction

11.11.4 Partec Revenue in HIV Diagnostics Business (2018-2023)

11.11.5 Partec Recent Developments

11.12 Sysmex

11.12.1 Sysmex Company Details

11.12.2 Sysmex Business Overview

11.12.3 Sysmex HIV Diagnostics Introduction

11.12.4 Sysmex Revenue in HIV Diagnostics Business (2018-2023)

11.12.5 Sysmex Recent Developments

11.13 Apogee Flow Systems

11.13.1 Apogee Flow Systems Company Details

11.13.2 Apogee Flow Systems Business Overview

11.13.3 Apogee Flow Systems HIV Diagnostics Introduction

11.13.4 Apogee Flow Systems Revenue in HIV Diagnostics Business (2018-2023)

11.13.5 Apogee Flow Systems Recent Developments

11.14 PointCare Technologies Inc.

11.14.1 PointCare Technologies Inc. Company Details

11.14.2 PointCare Technologies Inc. Business Overview

11.14.3 PointCare Technologies Inc. HIV Diagnostics Introduction

11.14.4 PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2018-2023)

11.14.5 PointCare Technologies Inc. Recent Developments

11.15 Zyomyx Inc.

11.15.1 Zyomyx Inc. Company Details

11.15.2 Zyomyx Inc. Business Overview

11.15.3 Zyomyx Inc. HIV Diagnostics Introduction

11.15.4 Zyomyx Inc. Revenue in HIV Diagnostics Business (2018-2023)

11.15.5 Zyomyx Inc. Recent Developments

11.16 Mylan inc.

11.16.1 Mylan inc. Company Details

11.16.2 Mylan inc. Business Overview

11.16.3 Mylan inc. HIV Diagnostics Introduction

11.16.4 Mylan inc. Revenue in HIV Diagnostics Business (2018-2023)

11.16.5 Mylan inc. Recent Developments

11.17 Roche Diagnostics

11.17.1 Roche Diagnostics Company Details

11.17.2 Roche Diagnostics Business Overview

11.17.3 Roche Diagnostics HIV Diagnostics Introduction

11.17.4 Roche Diagnostics Revenue in HIV Diagnostics Business (2018-2023)

11.17.5 Roche Diagnostics Recent Developments

11.18 Siemens Healthcare

11.18.1 Siemens Healthcare Company Details

11.18.2 Siemens Healthcare Business Overview

11.18.3 Siemens Healthcare HIV Diagnostics Introduction

11.18.4 Siemens Healthcare Revenue in HIV Diagnostics Business (2018-2023)

11.18.5 Siemens Healthcare Recent Developments

11.19 Qiagen

11.19.1 Qiagen Company Details

11.19.2 Qiagen Business Overview

11.19.3 Qiagen HIV Diagnostics Introduction

11.19.4 Qiagen Revenue in HIV Diagnostics Business (2018-2023)

11.19.5 Qiagen Recent Developments

11.20 BioMerieux

11.20.1 BioMerieux Company Details

11.20.2 BioMerieux Business Overview

11.20.3 BioMerieux HIV Diagnostics Introduction

11.20.4 BioMerieux Revenue in HIV Diagnostics Business (2018-2023)

11.20.5 BioMerieux Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

PointCare Technologies Inc

List of Tables

Table 1. Global HIV Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Consumables

Table 3. Key Players of Assay, Kits and Reagents

Table 4. Key Players of Other Consumables

Table 5. Key Players of Instruments

Table 6. Key Players of Software and Services

Table 7. Global HIV Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 8. Global HIV Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 9. Global HIV Diagnostics Market Size by Region (2018-2023) & (US$ Million)

Table 10. Global HIV Diagnostics Market Share by Region (2018-2023)

Table 11. Global HIV Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 12. Global HIV Diagnostics Market Share by Region (2024-2029)

Table 13. HIV Diagnostics Market Trends

Table 14. HIV Diagnostics Market Drivers

Table 15. HIV Diagnostics Market Challenges

Table 16. HIV Diagnostics Market Restraints

Table 17. Global HIV Diagnostics Revenue by Players (2018-2023) & (US$ Million)

Table 18. Global HIV Diagnostics Revenue Share by Players (2018-2023)

Table 19. Global Top HIV Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Diagnostics as of 2022)

Table 20. Global HIV Diagnostics Industry Ranking 2021 VS 2022 VS 2023

Table 21. Global 5 Largest Players Market Share by HIV Diagnostics Revenue (CR5 and HHI) & (2018-2023)

Table 22. Global Key Players of HIV Diagnostics, Headquarters and Area Served

Table 23. Global Key Players of HIV Diagnostics, Product and Application

Table 24. Global Key Players of HIV Diagnostics, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global HIV Diagnostics Market Size by Type (2018-2023) & (US$ Million)

Table 27. Global HIV Diagnostics Revenue Market Share by Type (2018-2023)

Table 28. Global HIV Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 29. Global HIV Diagnostics Revenue Market Share by Type (2024-2029)

Table 30. Global HIV Diagnostics Market Size by Application (2018-2023) & (US$ Million)

Table 31. Global HIV Diagnostics Revenue Share by Application (2018-2023)

Table 32. Global HIV Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 33. Global HIV Diagnostics Revenue Share by Application (2024-2029)

Table 34. North America HIV Diagnostics Market Size by Type (2018-2023) & (US$ Million)

Table 35. North America HIV Diagnostics Market Size by Type (2024-2029) & (US$ Million)

Table 36. North America HIV Diagnostics Market Size by Application (2018-2023) & (US$ Million)

Table 37. North America HIV Diagnostics Market Size by Application (2024-2029) & (US$ Million)

Table 38. North America HIV Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 39. North America HIV Diagnostics Market Size by Country (2018-2023) & (US$ Million)

Table 40. North America HIV Diagnostics Market Size by Country (2024-2029) & (US$ Million)

Table 41. Europe HIV Diagnostics Market Size by Type (2018-2023) & (US$ Million)

Table 42. Europe HIV Diagnostics Market Size by Type (2024-2029) & (US$ Million)

Table 43. Europe HIV Diagnostics Market Size by Application (2018-2023) & (US$ Million)

Table 44. Europe HIV Diagnostics Market Size by Application (2024-2029) & (US$ Million)

Table 45. Europe HIV Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 46. Europe HIV Diagnostics Market Size by Country (2018-2023) & (US$ Million)

Table 47. Europe HIV Diagnostics Market Size by Country (2024-2029) & (US$ Million)

Table 48. China HIV Diagnostics Market Size by Type (2018-2023) & (US$ Million)

Table 49. China HIV Diagnostics Market Size by Type (2024-2029) & (US$ Million)

Table 50. China HIV Diagnostics Market Size by Application (2018-2023) & (US$ Million)

Table 51. China HIV Diagnostics Market Size by Application (2024-2029) & (US$ Million)

Table 52. Asia HIV Diagnostics Market Size by Type (2018-2023) & (US$ Million)

Table 53. Asia HIV Diagnostics Market Size by Type (2024-2029) & (US$ Million)

Table 54. Asia HIV Diagnostics Market Size by Application (2018-2023) & (US$ Million)

Table 55. Asia HIV Diagnostics Market Size by Application (2024-2029) & (US$ Million)

Table 56. Asia HIV Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 57. Asia HIV Diagnostics Market Size by Region (2018-2023) & (US$ Million)

Table 58. Asia HIV Diagnostics Market Size by Region (2024-2029) & (US$ Million)

Table 59. Middle East, Africa, and Latin America HIV Diagnostics Market Size by Type (2018-2023) & (US$ Million)

Table 60. Middle East, Africa, and Latin America HIV Diagnostics Market Size by Type (2024-2029) & (US$ Million)

Table 61. Middle East, Africa, and Latin America HIV Diagnostics Market Size by Application (2018-2023) & (US$ Million)

Table 62. Middle East, Africa, and Latin America HIV Diagnostics Market Size by Application (2024-2029) & (US$ Million)

Table 63. Middle East, Africa, and Latin America HIV Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 64. Middle East, Africa, and Latin America HIV Diagnostics Market Size by Country (2018-2023) & (US$ Million)

Table 65. Middle East, Africa, and Latin America HIV Diagnostics Market Size by Country (2024-2029) & (US$ Million)

Table 66. Abbott Company Details

Table 67. Abbott Business Overview

Table 68. Abbott HIV Diagnostics Product

Table 69. Abbott Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 70. Abbott Recent Developments

Table 71. Abbott Healthcare Company Details

Table 72. Abbott Healthcare Business Overview

Table 73. Abbott Healthcare HIV Diagnostics Product

Table 74. Abbott Healthcare Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 75. Abbott Healthcare Recent Developments

Table 76. Abbvie Inc. Company Details

Table 77. Abbvie Inc. Business Overview

Table 78. Abbvie Inc. HIV Diagnostics Product

Table 79. Abbvie Inc. Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 80. Abbvie Inc. Recent Developments

Table 81. Brsitol-Myers Squibb Company Details

Table 82. Brsitol-Myers Squibb Business Overview

Table 83. Brsitol-Myers Squibb HIV Diagnostics Product

Table 84. Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 85. Brsitol-Myers Squibb Recent Developments

Table 86. Janssen Therapeutics Company Details

Table 87. Janssen Therapeutics Business Overview

Table 88. Janssen Therapeutics HIV Diagnostics Product

Table 89. Janssen Therapeutics Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 90. Janssen Therapeutics Recent Developments

Table 91. Gilead Sciences Company Details

Table 92. Gilead Sciences Business Overview

Table 93. Gilead Sciences HIV Diagnostics Product

Table 94. Gilead Sciences Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 95. Gilead Sciences Recent Developments

Table 96. Merck & Co. Inc Company Details

Table 97. Merck & Co. Inc Business Overview

Table 98. Merck & Co. Inc HIV Diagnostics Product

Table 99. Merck & Co. Inc Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 100. Merck & Co. Inc Recent Developments

Table 101. VIIV Healthcare Company Details

Table 102. VIIV Healthcare Business Overview

Table 103. VIIV Healthcare HIV Diagnostics Product

Table 104. VIIV Healthcare Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 105. VIIV Healthcare Recent Developments

Table 106. BD Biosciences Company Details

Table 107. BD Biosciences Business Overview

Table 108. BD Biosciences HIV Diagnostics Product

Table 109. BD Biosciences Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 110. BD Biosciences Recent Developments

Table 111. Beckman Coulter Company Details

Table 112. Beckman Coulter Business Overview

Table 113. Beckman Coulter HIV Diagnostics Product

Table 114. Beckman Coulter Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 115. Beckman Coulter Recent Developments

Table 116. Partec Company Details

Table 117. Partec Business Overview

Table 118. Partec HIV Diagnostics Product

Table 119. Partec Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 120. Partec Recent Developments

Table 121. Sysmex Company Details

Table 122. Sysmex Business Overview

Table 123. Sysmex HIV Diagnostics Product

Table 124. Sysmex Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 125. Sysmex Recent Developments

Table 126. Apogee Flow Systems Company Details

Table 127. Apogee Flow Systems Business Overview

Table 128. Apogee Flow Systems HIV Diagnostics Product

Table 129. Apogee Flow Systems Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 130. Apogee Flow Systems Recent Developments

Table 131. PointCare Technologies Inc. Company Details

Table 132. PointCare Technologies Inc. Business Overview

Table 133. PointCare Technologies Inc. HIV Diagnostics Product

Table 134. PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 135. PointCare Technologies Inc. Recent Developments

Table 136. Zyomyx Inc. Company Details

Table 137. Zyomyx Inc. Business Overview

Table 138. Zyomyx Inc. HIV Diagnostics Product

Table 139. Zyomyx Inc. Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 140. Zyomyx Inc. Recent Developments

Table 141. Mylan inc. Company Details

Table 142. Mylan inc. Business Overview

Table 143. Mylan inc. HIV Diagnostics Product

Table 144. Mylan inc. Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 145. Mylan inc. Recent Developments

Table 146. Roche Diagnostics Company Details

Table 147. Roche Diagnostics Business Overview

Table 148. Roche Diagnostics HIV Diagnostics Product

Table 149. Roche Diagnostics Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 150. Roche Diagnostics Recent Developments

Table 151. Siemens Healthcare Company Details

Table 152. Siemens Healthcare Business Overview

Table 153. Siemens Healthcare HIV Diagnostics Product

Table 154. Siemens Healthcare Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 155. Siemens Healthcare Recent Developments

Table 156. Qiagen Company Details

Table 157. Qiagen Business Overview

Table 158. Qiagen HIV Diagnostics Product

Table 159. Qiagen Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 160. Qiagen Recent Developments

Table 161. BioMerieux Company Details

Table 162. BioMerieux Business Overview

Table 163. BioMerieux HIV Diagnostics Product

Table 164. BioMerieux Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)

Table 165. BioMerieux Recent Developments

Table 166. Research Programs/Design for This Report

Table 167. Key Data Information from Secondary Sources

Table 168. Key Data Information from Primary Sources

List of Figures

Figure 1. Global HIV Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global HIV Diagnostics Market Share by Type: 2022 VS 2029

Figure 3. Consumables Features

Figure 4. Assay, Kits and Reagents Features

Figure 5. Other Consumables Features

Figure 6. Instruments Features

Figure 7. Software and Services Features

Figure 8. Global HIV Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 9. Global HIV Diagnostics Market Share by Application: 2022 VS 2029

Figure 10. Antibody Tests Case Studies

Figure 11. Viral Load Tests Case Studies

Figure 12. CD4 Tests Case Studies

Figure 13. Tests for Early Infant Diagnosis Case Studies

Figure 14. Tests for Viral Identification Case Studies

Figure 15. HIV Diagnostics Report Years Considered

Figure 16. Global HIV Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 17. Global HIV Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 18. Global HIV Diagnostics Market Share by Region: 2022 VS 2029

Figure 19. Global HIV Diagnostics Market Share by Players in 2022

Figure 20. Global Top HIV Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Diagnostics as of 2022)

Figure 21. The Top 10 and 5 Players Market Share by HIV Diagnostics Revenue in 2022

Figure 22. North America HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. North America HIV Diagnostics Market Share by Type (2018-2029)

Figure 24. North America HIV Diagnostics Market Share by Application (2018-2029)

Figure 25. North America HIV Diagnostics Market Share by Country (2018-2029)

Figure 26. United States HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. Canada HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Europe HIV Diagnostics Market Size YoY (2018-2029) & (US$ Million)

Figure 29. Europe HIV Diagnostics Market Share by Type (2018-2029)

Figure 30. Europe HIV Diagnostics Market Share by Application (2018-2029)

Figure 31. Europe HIV Diagnostics Market Share by Country (2018-2029)

Figure 32. Germany HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. France HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. U.K. HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. Italy HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. Russia HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. Nordic Countries HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. China HIV Diagnostics Market Size YoY (2018-2029) & (US$ Million)

Figure 39. China HIV Diagnostics Market Share by Type (2018-2029)

Figure 40. China HIV Diagnostics Market Share by Application (2018-2029)

Figure 41. Asia HIV Diagnostics Market Size YoY (2018-2029) & (US$ Million)

Figure 42. Asia HIV Diagnostics Market Share by Type (2018-2029)

Figure 43. Asia HIV Diagnostics Market Share by Application (2018-2029)

Figure 44. Asia HIV Diagnostics Market Share by Region (2018-2029)

Figure 45. Japan HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. South Korea HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. China Taiwan HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. Southeast Asia HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 49. India HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 50. Australia HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America HIV Diagnostics Market Size YoY (2018-2029) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America HIV Diagnostics Market Share by Type (2018-2029)

Figure 53. Middle East, Africa, and Latin America HIV Diagnostics Market Share by Application (2018-2029)

Figure 54. Middle East, Africa, and Latin America HIV Diagnostics Market Share by Country (2018-2029)

Figure 55. Brazil HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Mexico HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. Turkey HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 58. Saudi Arabia HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 59. Israel HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 60. GCC Countries HIV Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 61. Abbott Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 62. Abbott Healthcare Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 63. Abbvie Inc. Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 64. Brsitol-Myers Squibb Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 65. Janssen Therapeutics Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 66. Gilead Sciences Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 67. Merck & Co. Inc Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 68. VIIV Healthcare Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 69. BD Biosciences Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 70. Beckman Coulter Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 71. Partec Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 72. Sysmex Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 73. Apogee Flow Systems Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 74. PointCare Technologies Inc. Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 75. Zyomyx Inc. Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 76. Mylan inc. Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 77. Roche Diagnostics Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 78. Siemens Healthcare Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 79. Qiagen Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 80. BioMerieux Revenue Growth Rate in HIV Diagnostics Business (2018-2023)

Figure 81. Bottom-up and Top-down Approaches for This Report

Figure 82. Data Triangulation

Figure 83. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions